I agree that this site is using cookies. You can find further informations here.
X
Berabez, Rayan
13  results:
Search for persons X
?
1

Tetrahydropyridine LIMK inhibitors: Structure activity stud..:

Champiré, Anthony ; Berabez, Rayan ; Braka, Abdennour...
European Journal of Medicinal Chemistry.  271 (2024)  - p. 116391 , 2024
Link: https://doi.org/10.1016/..
 
?
2

LIM Kinases, Promising but Reluctant Therapeutic Targets: C..:

Berabez, Rayan ; Routier, Sylvain ; Bénédetti, Hélène..
Cells.  11 (2022)  13 - p. 2090 , 2022
Link: https://doi.org/10.3390/..
 
?
3

Hexafluoroisopropanol as the Acid Component in the Passerin..:

Saya, Jordy M. ; Berabez, Rayan ; Broersen, Pim...
Organic Letters.  20 (2018)  13 - p. 3988-3991 , 2018
Link: https://doi.org/10.1021/..
 
?
4

LIM kinases, promising but reluctant therapeutic targets: c..:

Berabez, Rayan ; Routier, Sylvain ; Bénédetti, Hélène..
info:eu-repo/semantics/altIdentifier/doi/10.3390/cells11132090.  , 2022
Link: https://hal.science/hal-..
 
?
5

LIM kinases, promising but reluctant therapeutic targets: c..:

Berabez, Rayan ; Routier, Sylvain ; Bénédetti, Hélène..
info:eu-repo/semantics/altIdentifier/doi/10.3390/cells11132090.  , 2022
Link: https://hal.science/hal-..
 
?
6

LIM kinases, promising but reluctant therapeutic targets: c..:

Berabez, Rayan ; Routier, Sylvain ; Bénédetti, Hélène..
info:eu-repo/semantics/altIdentifier/doi/10.3390/cells11132090.  , 2022
Link: https://hal.science/hal-..
 
?
7

LIM kinases, promising but reluctant therapeutic targets: c..:

Berabez, Rayan ; Routier, Sylvain ; Bénédetti, Hélène..
info:eu-repo/semantics/altIdentifier/doi/10.3390/cells11132090.  , 2022
Link: https://hal.science/hal-..
 
?
8

LIM kinases, promising but reluctant therapeutic targets: c..:

Berabez, Rayan ; Routier, Sylvain ; Bénédetti, Hélène..
info:eu-repo/semantics/altIdentifier/doi/10.3390/cells11132090.  , 2022
Link: https://hal.science/hal-..
 
?
9

LIM kinases, promising but reluctant therapeutic targets: c..:

Berabez, Rayan ; Routier, Sylvain ; Bénédetti, Hélène..
info:eu-repo/semantics/altIdentifier/doi/10.3390/cells11132090.  , 2022
Link: https://hal.science/hal-..
 
?
10

Hexafluoroisopropanol as the Acid Component in the Passerin..:

Saya, Jordy M ; Berabez, Rayan ; Broersen, Pim...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038100/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
11

Hexafluoroisopropanol as the Acid Component in the Passerin..:

Saya, Jordy M ; Berabez, Rayan ; Broersen, Pim...
Saya , J M , Berabez , R , Broersen , P , Schuringa , I , Kruithof , A , Orru , R V A & Ruijter , E 2018 , ' Hexafluoroisopropanol as the Acid Component in the Passerini Reaction : One-Pot Access to β-Amino Alcohols ' , Organic letters , vol. 20 , no. 13 , pp. 3988-3991 . https://doi.org/10.1021/acs.orglett.8b01561.  , 2018
Link: https://research.vu.nl/e..
 
?
12

LIM Kinases, Promising but Reluctant Therapeutic Targets: C..:

Rayan Berabez ; Sylvain Routier ; Hélène Bénédetti..
https://www.mdpi.com/2073-4409/11/13/2090.  , 2022
Link: https://doi.org/10.3390/..
 
?
13

LIM Kinases, Promising but Reluctant Therapeutic Targets: C..:

Rayan Berabez ; Sylvain Routier ; Hélène Bénédetti..
Cellular Pathology.  , 2022
Link: https://doi.org/10.3390/..
 
1-13